Immunocore Holdings (IMCR) Current Assets (2019 - 2026)

Immunocore Holdings has disclosed Current Assets across 8 years of filings, most recently posting $1.0 billion for Q1 2026.

• Current Assets for Q1 2026 came in at $1.0 billion, up 5.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 5.82% YoY), and the FY2025 annual result was $996.7 million, up 7.19% from the prior year.
• Current Assets came in at $1.0 billion for Q1 2026 at Immunocore Holdings, up from $996.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.0 billion in Q3 2025 to a low of $459.6 million in Q4 2022.
• The 5-year median for Current Assets is $956.9 million (2024), against an average of $889.2 million.
• Across the five-year window, Current Assets surged 75.84% in 2024 and advanced 1.68% in 2025, its largest moves.
• Immunocore Holdings' Current Assets stood at $459.6 million in 2022, then increased by 15.05% to $528.8 million in 2023, then jumped by 75.84% to $929.9 million in 2024, then increased by 7.19% to $996.7 million in 2025, then grew by 0.71% to $1.0 billion in 2026.
• The last three Current Assets figures came in at $1.0 billion (Q1 2026), $996.7 million (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.